Navigation Links
antibacterials in Medical News

Antibacterial chemical disrupts hormone activities

...understand, said one author, Bill Lasley, a UC Davis expert on reproductive toxicology and professor emeritus of veterinary medicine. More analyses of antibacterials and endocrine effects are planned, he said. Consumers should not take this study as guidance on whether to use triclocarban-containing products, La...

Infectious diseases experts applaud bill against 'bad bugs'

...son and Ferguson are taking to tackle the problem of antimicrobial resistance. Infectious diseases physicians have watched in dismay for years as the antibacterials and other antimicrobials we rely upon to treat our patients have lost their power. To make matters worse, there are very few new drugs in the pipel...

New Ribosome Finding Could Lead to Antiviral Therapies

...ding how these mutants affect the interactions between ribosomes and factors that lead to drug resistance can provide the foundation for design of new antibacterials to counter resistance of pathogens to drugs,” said Dinman. “This study also provides a basis for deeper insight into design of small molecule antivira...
antibacterials in Medical Technology

Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki

... products are targeting the global hospital antibiotic market, which was worth an estimated US$17bn in 2008.[1] Novexel currently has two novel antibacterials in Phase II clinical development. These are the injectable beta-lactamase inhibitor, NXL104, which is being developed in combination with the cephalos...

Rib-X Pharmaceuticals Novel Antibiotic Delafloxacin Named One of R&D Directions 100 Great Investigational Drugs of 2009

...ebsite at www.rib-x.com . (1) 100 Great Investigational Drugs; R&D Directions; March 2009 (2) Commercial and Pipeline Insight: Hospital antibacterials - A market beyond MRSA; Datamonitor; August 24, 2007 For further information please contact: Media: Irma Gomez-Dib FD Life Scie...

Novexel's NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs)

...et, which was worth an estimated $15bn in 2007 according to information derived from the IMS Midas(R) database. Novexel currently has two novel antibacterials in Phase II clinical development. These are the injectable beta-lactamase inhibitor, NXL104, which is being developed in combination with the cephalos...

Novexel's NXL104/ceftazidime Combination Commences Phase II Clinical Trial in Hospital Patients With Complicated Urinary Tract Infections

... market, which was worth an estimated $15bn in 2007 according to information derived from the IMS Midas(R) database. Novexel currently has two novel antibacterials in Phase II clinical development. These are the injectable beta-lactamase inhibitor, NXL104, which is being developed in combination with the cephalos...

Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (ICAAC/IDSA) Meeting

... market, which was worth an estimated $15bn in 2007 according to information derived from the IMS Midas(R) database. Novexel currently has two novel antibacterials in Phase II clinical development. These are the injectable beta-lactamase inhibitor, NXL104, which is being developed in combination with the cephalos...

Novexel Reports Positive Phase II Trial Results With NXL103 in Adult Patients With Community Acquired Pneumonia

... market, which was worth an estimated $15bn in 2007 according to information derived from the IMS Midas(R) database. Novexel currently has two novel antibacterials in Phase II clinical development. These are the injectable beta-lactamase inhibitor, NXL104, which is being developed in combination with the cephalos...

Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA

... 1:15 pm) -- F1-334: Discovery and SAR of a Novel Series of Pyrimidine antibacterials Targeting Methionyl-tRNA Synthase (MetRS) -- F1-335: In Vitro Activi...11:15 am - 12:15 pm) -- F2-2070: Structure Guided Design of Pyrimidine antibacterials Targeting Methionyl-tRNA Synthase (MetRS) Copies of these posters wil...

Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences

...re-Based Discovery to Define Novel Antibiotics Targeting the 50S Ribosomal Subunit." RX-04 is Rib-X's de novo design of three completely new series of antibacterials showing promising activity against serious multidrug resistant Gram-negative pathogens, including, Pseudomonas aeruginosa, Stenotrophomonas maltophili...
antibacterials in Biological News

New antibacterials being developed to tackle MRSA superbug

A novel antibacterial medicine that kills the superbug MRSA is being developed under a new scheme launched by the Wellcome Trust. The Seeding Drug Discovery initiative is aimed at catalysing the development of new drugs in areas of unmet need. Prolysis, an R&D company based in Oxford, has re...

Pharmaceutical use in Norwegian fish farming in 2001-2007

...r sea lice and fungi. The figures are based on sales from wholesalers to pharmacies and from feed mills to breeders. After an increase in sales of antibacterials from 2002-2006, sales in 2007 returned to levels seen in 2001. Prescription-based statistics from the Norwegian Food Safety Authority for the period 2...
antibacterials in Biological Technology

Novexel Strengthens its Scientific Advisory Board With the Appointment of Dr. Karen Bush

...'s products are targeting the global hospital antibiotic market, which was worth an estimated $17bn in 2008.[1] Novexel currently has two novel antibacterials in Phase II clinical development. These are the injectable beta-lactamase inhibitor, NXL104, which is being developed in combination with the cephalos...

Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing

...ion on the Rib-X mission and the pipeline, please visit the Company website at www.rib-x.com . (1) Commercial and Pipeline Insight: Hospital antibacterials - A market beyond MRSA; Datamonitor; August 24, 2007 ...

GlaxoSmithKline to Acquire Genelabs Technologies to Increase Focus on Novel Small Molecule Therapies for Hepatitis C

...r in an entrepreneurial environment and size of small biotechnology companies. The ID CEDD currently consists of three discovery units for antivirals, antibacterials and medicines against diseases of the developing world. It focuses on building an innovative pipeline through both internal efforts and external allia...

GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program

...he U.S. Department of Defense (DOD), to identify and develop a new class of antibacterials targeting both Gram negative biothreats and conventional Gram negative hosp...e Threat Reduction Agency. "This research is needed to identify and deliver antibacterials from entirely new classes to defend against potential biothreat outbreaks a...
antibacterials in Biological Definition

Antibiotic

...ic corticosteroid . Antibiotic misuse Common forms of antibiotic misuse include taking an inappropriate antibiotic, in particular the use of antibacterials for viral infections like the common cold, and failure to take the entire prescribed course of the antibiotic, usually because the patient feels bette...
Other Tags
(Date:4/21/2015)... 2015 QuickMedical, a veteran-owned leader ... now represents Schiller America's line of ... Tests, and Vital Signs Monitors, among many other ... a global leader in the development and production ... in close cooperation with the world's leading physicians ...
(Date:4/21/2015)... Respected academic institution selects Visage 7 ... Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of ... seven-year contract with University of Florida Health — a ... deal furthers the penetration of Visage 7 ... of the North American enterprise imaging market. Visage ...
(Date:4/21/2015)... Baltimore, Maryland (PRWEB) April 21, 2015 ... air, according to the U.S. Environmental Protection Agency (EPA). ... UV rays and cigarette smoke increase the level of ... help the body eliminate these harmful toxins is to ... superfood, broccoli boasts the highest level of glucoraphanin – ...
(Date:4/21/2015)... PA (PRWEB) April 21, 2015 Health ... company and a subsidiary of West Corporation, is hosting ... Health Advocacy solution and the benefits of offering this ... on more responsibility for managing their healthcare, it is ... information necessary to effectively utilize their health benefits. Health ...
(Date:4/21/2015)... April 21, 2015 Le Petit Retreat Day ... its doors today in the leafy, historic Larchmont neighborhood, newly ... and a new theme of “Disconnect to Reconnect.” Tina ... of the award-winning day spa, announces the new name and ... Mother’s Day offerings that help celebrate connections with Moms and ...
Breaking Medicine News(10 mins):Health News:QuickMedical Launches New Product Line: Schiller America 2Health News:QuickMedical Launches New Product Line: Schiller America 3Health News:Visage Imaging Signs University of Florida Health 2Health News:Visage Imaging Signs University of Florida Health 3Health News:Visage Imaging Signs University of Florida Health 4Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 2Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 3Health News:Health Advocate Webinar Discusses Benefits of Health Advocacy 2Health News:Larchmont Sanctuary Spa Revealed as New Name For Neighborhood Spa; New Owner, New Eco Offerings & New Theme: “Disconnect to Reconnect” 2Health News:Larchmont Sanctuary Spa Revealed as New Name For Neighborhood Spa; New Owner, New Eco Offerings & New Theme: “Disconnect to Reconnect” 3
(Date:3/24/2015)... PALM BEACH GARDENS, Fla. , March 24, ... of biometric identity management solutions, today announced that ... enabling premium clothing accessory retailer Goorin Bros ... login. The Crossmatch biometrics-based solution secures access to ... customers from the increased risk of data breaches. ...
(Date:3/23/2015)... 23, 2015  In the 2014 fiscal year, irs.gov ... losses. This figure accounts for a fraction of the ... Nilson Report, exceeds $11 billion globally. The polygraph has ... crime has occurred. Investor Mark Saint Juste ... Joe Paolella partnered to administer the test in ...
(Date:3/20/2015)... , Mar. 19, 2015 Research and Markets ... "Hand Geometry - Global Strategic Business Report" report ... markets for Hand Geometry in US$ Thousands. The report provides ... , Japan , Europe ... , and Rest of World. Annual estimates ...
Breaking Biology News(10 mins):Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4
Other Contents